Back to top

Termination Agreement to Master Clinical Services Agreement and Work Order No. 1 and 2

Termination Agreement

Termination Agreement to Master Clinical Services Agreement and Work Order No. 1 and 2 | Document Parties: ICON Clinical Research Limited | Neurobiological Technologies, Inc You are currently viewing:
This Termination Agreement involves

ICON Clinical Research Limited | Neurobiological Technologies, Inc

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: Termination Agreement to Master Clinical Services Agreement and Work Order No. 1 and 2
Date: 6/2/2009
Industry: Biotechnology and Drugs     Law Firm: Goodwin Procter     Sector: Healthcare

Termination Agreement to Master Clinical Services Agreement and Work Order No. 1 and 2, Parties: icon clinical research limited , neurobiological technologies  inc
50 of the Top 250 law firms use our Products every day

Exhibit 10.1

Termination Agreement
to
Master Clinical Services Agreement
and
Work Order No. 1 and 2
(also referred to as Work Order A and B)

 

 

 

DATED

 

29 May 2009 (the “Effective Date”)

 

 

 

BETWEEN

 

Neurobiological Technologies, Inc., 2000 Powell Street, Suite 800, Emeryville, California 94608 USA (“Sponsor”)

 

 

 

AND

 

ICON Clinical Research Limited of South County Business Park, Leopardstown, Dublin 18, Ireland (“Service Provider”).

 

 

 

WHEREAS:

 

 

 

A.

 

The parties entered into a Master Clinical Services Agreement for Services dated 16 th January 2007 (the “Agreement”).

 

B.

 

Thereafter the parties entered into a Work Order No. 1, dated the 16 th of May 2007, concerning a study known as “Study of Acute Viprinex TM for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex TM ) in Subjects Beginning Treatment within 6 Hours of the Onset of Acute, Ischemic Stroke (ASP-1)”, Protocol NTI-ASP-0502” (the “Work Order No. 1”), as amended by Change Order No. 1 dated the 9 th November 2007 (“Study No. 1”).

 

C.

 

Thereafter the parties entered into a Work Order No. 2, dated the 16 th of May 2007, concerning a study known as “ASP-II (Ancrod in Stroke program – II): A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex TM ) for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex TM ) in Subjects Beginning Treatment within 6 Hours of the Onset of Acute, Ischemic Stroke”, Protocol NTI-ASP-0503” (the “Work Order No. 2”) as amended by Change Order No. 1 dated the 9 th November 2007 (“Study No. 2”).

 

D.

 

The parties also now wish to terminate the Agreement and Work Order No.1 and Work No. 2 (collectively the “Work Orders”), as well as any and all Change Orders to the Work Orders, subject to the terms and conditions set forth in this Termination Agreement

In consideration of the premises and mutual promises and covenants herein contained, the adequacy of which is acknowledged by each of the parties, IT IS AGREED BY THE PARTIES AS FOLLOWS:

1.         Termination of Agreement and Work


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more